News Releases
Search and Filter
Results per Page:
Fred Hutch completes move-in of Lake Union Steam Plant
106,000-square-foot facility will be home to transformative data science and immunotherapy research aimed at faster cancer breakthroughs
Fred Hutch opens COVID-19 Clinical Research Center
Newly renovated facility is among the first stand-alone centers specifically designed to test novel interventions such as monoclonal antibodies and antivirals to treat and prevent COVID-19
Tip Sheet: Cancer health disparities, app to stop smoking, diversity in COVID-19 vaccine trials — and more
Summaries of recent Fred Hutch research findings and other news, plus resources for October's Breast Cancer Awareness Month
Study reveals element in blood is part of human — and hibernating squirrel — stress response
The element iodide’s ability to dampen the harm of stress-induced inflammation points to potential uses in treating traumatic injuries and COVID-19
Fred Hutch Obliteride raises more than $3 million in 2020
Fundraising exceeds organizers’ expectations in unprecedented pandemic era
Fred Hutch-led clinical trial shows new smartphone app helps smokers quit
JAMA Internal Medicine study shows iCanQuit app, based on acceptance and commitment therapy, is 1 1/2 times more efficacious than National Cancer Institute QuitGuide app, based on US clinical practice guidelines
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
New gene therapy approach eliminates at least 90% latent herpes simplex virus 1
In Nature Communications, Fred Hutch scientists demonstrate in a mouse model how gene therapy could cure an infection that afflicts billions of people
Tip Sheet: COVID-19 vaccines, COVID-19 and cancer patients, smoking cessation apps, structural racism in medicine – and more
Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Seattle to Glow Orange to Support Fred Hutch Cancer, COVID-19 Research
Thousands from around the world are participating in Fred Hutch Obliteride 2020
Fred Hutch joins international COVID-19 vaccine effort
New clinical trials network will evaluate vaccines and antibodies to prevent COVID-19
Fred Hutch announces reductions in workforce
In response to economic impact from COVID-19, Fred Hutch laid off 76 employees from its South Lake Union campus and eliminated 81 open positions
Fred Hutch announces new additions and leadership to board of trustees
Kathy Surace-Smith elected as new chair; Leigh Morgan takes on vice chair position; Connie Kravas and Pete Shimer become newest members
Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives
New review article in Open Forum Infectious Diseases suggests “golden opportunity being missed”
Join Drs. Larry Corey and John Mascola for a discussion on COVID-19 vaccines
Hear from two global experts about how existing partnerships, networks and infrastructure can be used to develop, test and distribute vaccines safely and effectively, in record time
Fred Hutch Obliteride changes gears, shifts to individual events for 2020
Obliteride goes global to accelerate cancer and COVID-19 research
Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemotherapy
Project will focus on reducing unplanned emergency department visits through a remote monitoring system